MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cvr/cvaf100

Медицинская библиотека · Cardiovascular research · 2025

Platelets and inflammation-insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial.

Gutmann Clemens, Barwari Temo, Schulte Christian, Theofilatos Konstantinos, Singh Bhawana, Takov Kaloyan, Suna Gonca, Chan Melissa V, Armstrong Paul C, Cassel Christian, Ueki Yasushi, Häner Jonas D, Santer Peter, Willeit Peter, Hengstenberg Christian, Räber Lorenz, Kiechl Stefan, Willeit Johann, Warner Timothy D, Mayr Manuel

Клиническое исследование II фазыСтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIMS: Platelets contain non-coding RNAs (ncRNAs), and their measurement may complement platelet aggregometry.

METHODS AND

RESULTS

In the community-based Bruneck study (n = 338), we generated platelet-rich plasma (PRP), platelet-poor plasma (PPP), and platelets. PRP was subjected to aggregometry using various agonists and processed to platelet releasates thereafter. Releasates, PPP, and platelets underwent real-time polymerase chain reactions to measure ncRNAs. Platelet ncRNA release appeared agonist-specific, dose-dependent, and inhibited by aspirin. Collagen triggered the strongest release for most ncRNAs, whereas miR-150 was hyperresponsive to ADP, and miR-21 was hyperresponsive to arachidonic acid. Comparing the dynamic range of ncRNA release to aggregation, aggregation reached a maximum at high agonist concentrations, while ncRNAs continued to rise. Cohort-wide associations showed that inflammation parameters like neutrophil counts and C-reactive protein correlated inversely with platelet aggregation and ncRNA release. Similarly, a high leucocyte-derived RNA content in isolated platelets correlated inversely with aggregation. Inverse correlations were absent in aspirin users. Through experiments on plasma-free platelet releasates and platelets, including size-exclusion chromatography, ultracentrifugation, and degradation assays, we discovered that microRNAs and YRNAs are carried by proteins and readily released, while circular-, long non-coding-, and messenger RNAs are carried by vesicles and preferentially retained. Finally, we assessed ncRNA responses to short- and long-term dual anti-platelet therapy (DAPT) in plasma from 265 patients with acute myocardial infarction (AMI) of the PACMAN-AMI trial. Most of the DAPT effect was already achieved by 4 weeks, with a further reduction at 52 weeks, revealing a short- and long-term DAPT effect not captured by aggregometry.

CONCLUSION

Inflammation and leucocyte-derived RNAs in isolated platelets are associated with reduced platelet responses ex vivo, potentially reflecting exhaustion through pre-activation in vivo. We show that protein-bound ncRNAs are readily released from platelets, whereas vesicle-bound ncRNAs are preferentially retained. We highlight the potential of ncRNAs as biomarkers complementing aggregometry.

Для цитирования: Gutmann Clemens, Barwari Temo, Schulte Christian, Theofilatos Konstantinos, Singh Bhawana, Takov Kaloyan, Suna Gonca, Chan Melissa V, Armstrong Paul C, Cassel Christian, Ueki Yasushi, Häner Jonas D, Santer Peter, Willeit Peter, Hengstenberg Christian, Räber Lorenz, Kiechl Stefan, Willeit Johann, Warner Timothy D, Mayr Manuel. Platelets and inflammation-insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial.. Cardiovascular research. 2025. DOI: 10.1093/cvr/cvaf100.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.